Armotraz also known as Indian Generic ARIMIDEX, is a prescription aromatase inhibitor indicated for:
1. Adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer
2.First-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer
3.Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with ER-negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to Armotraz
Armotraz’s brand name in usa is ARIMIDEX by AstraZeneca. Armotraz’s is a generic prescription medicine from Cipla, which is one of the biggest pharmaceutical company in India.
Warning and Precautions:
In women with pre-existing ischemic heart disease, an increased incidence of ischemic cardiovascular events occurred with Armotraz use compared to tamoxifen use. Consider risks and benefits